CMS issues 2018 Medicare Advantage, prescription drug plan star ratings
The Centers for Medicare & Medicaid Services this week published its star ratings for 2018 Medicare Advantage and prescription drug plans. Approximately 44% of MA plans that offer prescription drug coverage will have an overall rating of four stars or higher in 2018, and about 52% of stand-alone prescription drug plans will have a rating of four stars or higher in 2018. Open enrollment for 2018 MA and prescription drug plans begins Sunday and ends Dec. 7. CMS recently released premium and cost information for MA and Part D prescription drug plans for the 2018 calendar year.
Related News Articles
Headline
The AHA July 11 released its quarterly Health Care Plan Accountability Update, a roundup of news, letters, statements and other resources covering private…
Headline
The AHA submitted a statement July 11 for a Senate Special Committee on Aging hearing on health care transparency and lowering health care costs. The AHA…
Headline
The Healthcare Equality Network July 3 sent a letter to the Centers for Medicare & Medicaid Services, expressing concerns about claims denials by…
Headline
The Department of Health and Human Services’ Office of Inspector General last week announced its intent to investigate Medicare Advantage Organizations’ prior…
Headline
The Medicare Payment Advisory Commission June 13 released its June report to Congress. As urged by the AHA, the commission did not recommend a payment…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…